Home > Drug Search >
  • Targets: Farnesyltransferase
  •   > 
Drug Filter
Category:
chemistry (25) biology (1)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (10)
Clinical Stage:
Pending (4) Active (8) Discontinued (12)
Company:
Denovo Biopharma (1) Exelixis (1) Janssen (1) Johnson & Johnson (1) Lilly (8) Merck Serono (1) Merck Sharp & Dohme (2) National Cancer Institute (1) Novartis (1) Pfizer (1) Roche (1) Taisho Pharmaceutical (2) Institute of Phytochemistry (1) Merck (1) Astex Pharmaceuticals (1) Addex Therapeutics (1) Eiger BioPharmaceuticals (2) BrainCells (2) National Institute on Drug Abuse (1) Amgen (1) AstraZeneca (3) Bristol-Myers Squibb (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Anxiety (2) Breast cancer (2) Oedema (1) Cognitive disorders (1) Depression (2) Generalised anxiety disorder (GAD) (1) Hypertension (1) Lung cancer (2) Major depressive disorder (MDD) (1) Migraine (2) Pancreatic cancer (1) Rheumatoid arthritis (RA) (1) Schizophrenia (3) Smoking cessation (1) Solid tumours (5) Head and neck cancer (1) Colorectal cancer (1) Pain (1) Post-traumatic stress disorder (1) HDV infection (2) Panic disorder (1) Neurodegeneration (1) Liver cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top